Skip to main content

Table 1 Baseline characteristics of the patients

From: Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

 

Viable

Non-viable

 

Invasive

Conservative

 

P- value*

Characteristic

(n = 106)

(n = 110)

(n = 75)

 

Male

75%

81%

66%

0.41

Age (yrs)

60

59

64

0.52

Clinical history (%)

    

Angina

41%

44%

54%

0.68

Myocardial infarction

6%

4%

9%

0.53

Percutaneous coronary intervention

2%

3%

9%

1.0

Coronary- artery bypass grafting

0%

1%

1%

1.0

Risk factors (%)

    

Dabetes mellitus

8%

13%

12%

0.26

Hypertension

27%

28%

30%

1.0

Hypercholesterolemia

19%

14%

18%

0.36

Current sigaret smoking

45%

40%

64%

0.49

Family history of CAD

33%

31%

20%

0.77

Medications at admission (%)

    

Aspirin

17%

9%

14%

0.11

Beta- blocker

12%

12%

18%

1.0

Ca- inhibitor

9%

4%

8%

0.16

Statins

15%

6%

12%

0.02

ACE- inhibitor

8%

6%

15%

0.59

AT II antagonist

6%

6%

5%

1.0

Time from onset of symptoms To randomization-hr

73± 32

69± 25

78± 31

0.53

Time from onset of symptoms To thrombolysis-minutes

184± 155

200± 147

190± 112

0.65

Thrombolysis

53%

45%

47%

0.34

Anterior infarction

31%

33%

47%

0.88

Ejection Fraction (EF%)

52.7

54.7

53.5

0.32

Randomization to revascularization

    

   mean (days)

5.6

   

   median (days)

2

   

Occluded IRA (%)

19.8

   

Absence of collaterals (%)

63.2

   

Protocol PCI (%)

73

   

CABG (%)

11

   

No revascularization (%)

16

   
  1. * Differences between the randomized groups are expressed with a P-value. Plus-minus values are means ± SD.